Kamada's rabies drug succeeds in trial

(Reuters) - Israeli drugmaker Kamada Ltd said its rabies therapy was found as effective as a reference drug in a large trial and it would file for a U.S. approval for the therapy by mid-2016.

Source: Reuters: Health - December 23, 2015 Category: Consumer Health News Tags: healthNews Source Type: news